Home
Research
Overview
Cardiovascular Regenerative Medicine
Biomaterials for Tissue Engineering
Drug Delivery
Biomaterial Interactions
Dental Materials
Orthopaedic Repair and Regeneration
Drive to Commercialization
Educational Videos
News
Recent Publications
People
Paul Santerre
Current Members
Connect
Opportunities
Contact

Santerre Lab

Home
Research
Overview
Cardiovascular Regenerative Medicine
Biomaterials for Tissue Engineering
Drug Delivery
Biomaterial Interactions
Dental Materials
Orthopaedic Repair and Regeneration
Drive to Commercialization
Educational Videos
News
Recent Publications
People
Paul Santerre
Current Members
Connect
Opportunities
Contact
Dr Santerre appointed Baxter Chair of Health Technology and Commercialization
March 8, 2018
Santerre Lab
Dr Santerre appointed Baxter Chair of Health Technology and Commercialization
Santerre Lab
March 8, 2018

Dr Santerre appointed Baxter Chair of Health Technology and Commercialization

Santerre Lab
March 8, 2018

Dr Paul Santerre has been appointed the Baxter Chair of Health Technology and Commercialization, created through a $2.5 million -investment by the Baxter Corporation to the University Health Network to drive entrepreneurship and commercialization initiatives at both the University Health Network and the University of Toronto. Read more about his appointment here.

Newer PostSummer research experiences at the Santerre Lab
Older PostSanterre lab member Jeremy Antonyshyn presents his research at the 15th Annual Meeting of the International Federation for Adipose Therapeutics and Science
Back to Top
Santerre Lab at IBBME, 661 University Ave, Toronto, ON, M5G 1M1, Canada